SS
AZN icon

Steve Schonfeld’s AstraZeneca AZN Stock Holding History

Steve Schonfeld’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-950
Closed -$146K – 2054
2025
Q3 		$146K Buy
+950
New +$144K ﹤0.01% 1986
2023
Q3 		– Sell
-175,000
Closed -$1.26M – 1776
2023
Q2 		$1.26M Sell
175,000
-100,000
-36% -$14.7M 0.01% 904
2023
Q1 		$453K Buy
+275,000
New +$37M ﹤0.01% 1207

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Steve Schonfeld's AZN Position: Q2 2026 in Review

Steve Schonfeld sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 42,071 shares — an estimated $8.3M sold.

Steve Schonfeld first reported a position in AZN in Q1 2016 and held it in 26 quarters. The position peaked at $66.6M in Q3 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Steve Schonfeld reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Steve Schonfeld sold 42,071 AstraZeneca shares in Q2 2026, an estimated $8.3M.
  • Steve Schonfeld first reported a position in AstraZeneca in Q1 2016 and held it in 26 quarters.
  • Steve Schonfeld's AstraZeneca position peaked at $66.6M in Q3 2025.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.